Search for: "BRISTOL-MYERS SQUIBB"
Results 421 - 440
of 863
Sort by Relevance
|
Sort by Date
31 Oct 2013, 5:26 am
See Bristol-Myers Squibb Co. v. [read post]
30 Oct 2013, 2:08 pm
In reviewing the current Bristol-Myers Squibb/Sanofi Pharmaceuticals Plavix Prescribing Information (label revised 9/23/13; accessed 10/30/13), however, there is no mention of hemophilia (nor haemophilia) in that document. [read post]
22 Oct 2013, 2:28 pm
Bristol-Myers Squibb Co., et al. v. [read post]
22 Oct 2013, 11:59 am
Bydureon (January 27, 2012) (Amylin / Eli Lilly)Liraglutide Victoza (January 25, 2010) (Novo Nordisk)Sitagliptin Januvia (October 16, 2006) (Merck) Janumet (March 30, 2007) (Merck) Janumet XR (February 2, 2012) (Merck) Juvisync (October 7, 2011) (Merck)Saxagliptin Onglyza (July 31, 2009) (Bristol Myers Squibb) Kombiglyze XR (November 5, 2010) (Bristol Myers Squibb)Alogliptin Nesina (January 25,… [read post]
18 Sep 2013, 2:05 pm
In the U.S. market, Xarelto competes with Eliquis, sold by Pfizer and Bristol-Myers Squibb, and with Boehringer Ingelheim's Pradaxa.The next day's Reuters news report presented the German drug regulator reaction to this Xarelto Der Spiegel magazine article about Xarelto: The number of reported side effects linked to Bayer's stroke prevention pill Xarelto is below worrisome levels, a German drugs regulator said, responding to a media report highlighting risks from taking… [read post]
15 Sep 2013, 11:57 pm
Recently Dasatinib made news when the economic times reported that “The Indian Patent Office has rejected Mumbai-based BDR Pharmaceutical's application for compulsory licence on cancer drug Dasatinib, according to an affidavit filed by Bristol Myers Squibb, the patent holder for the drug. [read post]
5 Aug 2013, 9:59 pm
The UK High Court recently gave its judgment in the case of Merck, Sharp & Dohme Corp. and Bristol-Myers Squibb Pharmaceuticals Ltd (collectively referred to in the judgement as BMS) v Teva Pharma B.V. and Teva UK Ltd (Teva) (decision). [read post]
1 Aug 2013, 9:29 am
The generic and brand names of the drugs in this family include: • Exenatide (Byetta & Bydureon) marketed by Bristol Myers-Squibb and Amylin Pharmaceuticals, Inc. [read post]
30 Jul 2013, 1:34 pm
In addition to the European agency, the Food and Drug Administration has been reviewing the safety of a big class of drugs that includes Januvia by Merck and the drugs Byetta, Bydureon and Onglyza, which are sold by Bristol-Myers Squibb and AstraZeneca. [read post]
30 Jul 2013, 1:34 pm
In addition to the European agency, the Food and Drug Administration has been reviewing the safety of a big class of drugs that includes Januvia by Merck and the drugs Byetta, Bydureon and Onglyza, which are sold by Bristol-Myers Squibb and AstraZeneca. [read post]
30 Jul 2013, 1:34 pm
In addition to the European agency, the Food and Drug Administration has been reviewing the safety of a big class of drugs that includes Januvia by Merck and the drugs Byetta, Bydureon and Onglyza, which are sold by Bristol-Myers Squibb and AstraZeneca. [read post]
30 Jul 2013, 1:34 pm
In addition to the European agency, the Food and Drug Administration has been reviewing the safety of a big class of drugs that includes Januvia by Merck and the drugs Byetta, Bydureon and Onglyza, which are sold by Bristol-Myers Squibb and AstraZeneca. [read post]
29 Jul 2013, 2:24 am
Unfortunately,without any thumbs, he was unable to forwardthem to the true recipient, Bristol-Myers Squibb When the parties engaged in correspondence, Teva refused to divulge its launch plans as it considered these plans confidential. [read post]
28 Jul 2013, 9:29 am
Byetta, now sold by Bristol-Myers Squibb and AstraZeneca, was approved in 2005 and contained a warning about pancreatitis. [read post]
8 Jul 2013, 8:10 am
Bristol-Myers Squibb Co., 2013 U.S. [read post]
3 Jul 2013, 3:12 pm
There have been an increasing number of lawsuits filed against the manufacturers of these drugs, Merck and Bristol-Myers Squibbs. [read post]
14 Jun 2013, 9:22 pm
Kevin Noonan of McDonnell Boehnen Hulbert & Berghoff; and Paul Golian, Assistant General Counsel at Bristol-Myers Squibb Company will consider such questions as: • How many and which existing gene patents will be challenged in post-grant proceedings at the USPTO? [read post]
14 Jun 2013, 6:23 pm
The Food and Drug Administration said it is considering setting up a study, either through the agency or the companies, that looks deeper into whether medicines for Type 2 diabetes, including Merck’s Januvia and Bristol Myers-Squibb Co. [read post]
12 Jun 2013, 12:50 pm
The concerns relate to a number of widely prescribed GLP-1–based therapies, the 2 injectable GLP-1 agonists, exenatide (Byetta, Amylin/Lilly) and liraglutide (Victoza, Novo Nordisk), and the oral DPP-4 inhibitors sitagliptin, saxagliptin (Ongylza, AstraZeneca/Bristol-Myers Squibb), and linagliptin (Tradjenta, Boehringer Ingelheim/Lilly). [read post]
10 Jun 2013, 11:23 am
Thakur began his work at Ranbaxy in early 2004 after he was recruited from the brand-name pharmaceutical company Bristol-Myers Squibb (BMY) based out of New Jersey. [read post]
